Freeline Therapeutics Holdings plc
(NASDAQ CM: FRLN)
Rigrodsky Law, P.A. is investigating Freeline Therapeutics Holdings plc (“Freeline”) regarding possible breaches of fiduciary duties and other violations of law related to Freeline’s agreement to be acquired by Syncona Ltd. Under the terms of the agreement, Freeline shareholders will receive $6.50 per share in cash.